Synthesis of CCN (colchicine-cyanonilutamide conjugate, 5 grams)
Ended Purchase Order Awarded
- Contract number
- HHSN261200800307P
- Awardee
-
Concord Biosciences, LLC UEI PK2WJZ5N4KF4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,349
Award facts
- Contract value 100% obligated
- $21,349.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Painesville, OH 44077, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261200800307P?
HHSN261200800307P was awarded to Concord Biosciences, LLC by National Cancer Institute (National Institutes of Health) on March 27, 2008.
How much is contract HHSN261200800307P worth?
The government has obligated $21,349 on HHSN261200800307P.
Which agency awarded contract HHSN261200800307P?
National Cancer Institute (National Institutes of Health) awarded HHSN261200800307P, with funding from Office of the Director (National Institutes of Health).
Was contract HHSN261200800307P competed?
The extent of competition for HHSN261200800307P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award